Widgets for Webmasters
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. ... Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Merck's migraine pain treatment... [read full story]
|
Full Coverage
|
|
The U.S. Food and Drug Administration announced it has determined the generic antidepressant Budeprion XL is both safe and effective. ... The agency said it had received reports of loss of antidepressant effect, and new or worsening side effects, in some patients who...
Teva Pharmaceuticals USA issues the following statement in response to the "Review of Therapeutic Equivalence Generic Bupropion XL 300 mg and Wellbutrin XL 300 mg" released by FDA on April 16, 2008: As the largest generic drug company in the world, Teva's first priority is to ensure that patients...
Federal regulators said Wednesday Teva Pharmaceutical's generic version of a popular antidepressant is safe and effective, despite a spate of recent consumer complaints. ... The Food and Drug Administration agreed to review Teva's version of Wellbutrin after dozens of...
FDA Review Finds Tevas Generic Version Of Wellbutrin Safe, Effective ... April 17, 2008 (FinancialWire) The Food and Drug Administration has cleared Teva Pharmaceutical s, a unit of Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), generic version of GlaxoSmithKline Plc...
Teva Pharmaceutical Industries Ltd. said Thursday the Food and Drug Administration granted tentative approval for its abbreviated new drug application to market a generic version of Eli Lilly & Co.'s osteoporosis treatment Evista tablets, 60 mg. The Israel drug manufacturing company said it is in...
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. ... Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Lilly's osteoporosis treatment...
Teva Pharmaceutical Industries has said that the FDA has granted tentative approval for the company's abbreviated new drug application to market its generic version of Lilly's osteoporosis treatment Evista tablets, 60mg. ... Teva is currently involved in patent...
Pharmaceutical company Teva Pharmaceutical Industries Ltd (Nasdaq:TEVA) reported on 17 April the receipt of a tentative approval from the US Food and Drug Administration (FDA) for the company's Abbreviated New Drug Application (ANDA) to market its generic
Teva Pharmaceutical Industries has announced that the FDA has granted tentative approval for the company's abbreviated new drug application to market rizatriptan benzoate tablets. ... Rizatriptan benzoate is a generic version of Merck's migraine pain treatment Maxalt...
Teva Pharmaceutical Industries Ltd (Nasdaq: TEVA), a pharmaceutical company, said on 17 April that the company has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) to market the generic

